Advances in the Management of Cardiovascular Disease in the Setting of Human Immunodeficiency Virus

Abstract

This state-of-the art review discusses the underlying mechanisms that contribute to atherosclerotic cardiovascular disease, heart failure and arrhythmias among people with human immunodeficiency virus (HIV), risk prediction and prevention, management, and outstanding research questions, including a discussion of how the Randomized Trial to Prevent Vascular Events in HIV may inform clinical practice.

Keywords: Antiretroviral therapy; Cardiovascular diseases; Cardiovascular risk; HIV.